The European Medicines Agency (EMA) has recommended to grant MediWound marketing authorization for NexoBrid™ in the European Union (EU) for removal of eschar in adult patients with deep partial- and/or full-thickness thermal burns. This approval follows EMA’s Good Manufacturing Practices (cGMP) approval for MediWound’s sterile manufacturing plant and laboratories. NexoBrid™...
Read more
Category Archives: wound healing
CollPlant Wound Closure Trial Success
CollPlant has successfully completed a wound closure clinical study opening the path toward regulatory certifications required for commercialization of CollPlant’s products. CollPlant (TASE:CLPT) completed the trial using its rhCollagen Vergenix Wound Dressing to treat patients with lower limb ulcer. The objective of the study was to assess the safety and...
Read more
CollPlant Wound Trial Interim Results
CollPlant Holdings Ltd. (TASE: CLPT) reported successful interim results in a preclinical (animal) trial its VergenixFG wound dressing gel made of pure recombinant human collagen, for the treatment of skin lesions. The trial found that the product was effective and had statistically significant better results than corresponding products on the...
Read more
Mentor for Medical Device Startup: Vascular Procedures
The US Israel Business Council is seeking mentors to work with promising Israeli startups. In the medical device arena the Council has selected HDH Medical. The startup has developed and commercialized a platform technology for creating suture-less anastomosis in hollow organs, including the treatment of occlusions, aneurysms and traumas in vascular surgery....
Read more